Literature DB >> 34206597

A Possible Role for HSV-1-Specific Humoral Response and PILRA rs1859788 Polymorphism in the Pathogenesis of Parkinson's Disease.

Simone Agostini1, Roberta Mancuso1, Andrea S Costa1, Lorenzo A Citterio1, Franca R Guerini1, Mario Meloni1, Jorge Navarro1, Mario Clerici1,2.   

Abstract

The etiology of Parkinson's disease (PD), a progressive nervous system disorder that affects movement, is still unknown; both genetic and environmental factor are believed to be involved in onset of the disease and its development. Herpes simplex virus type 1 (HSV-1), in particular, is suspected to have a role in PD. Paired Immunoglobulin-like type 2 receptor alpha (PILRA) is an inhibitory receptor that down-regulates inflammation and is expressed on innate immune cells. The PILRA rs1859788 polymorphism is protective against Alzheimer's disease, even in relation with HSV-1 antibody titers, but no data are available in PD. We analyzed HSV-1 antibody titers and PILRA rs1859788 in PD (n = 51) and age-and sex-matched healthy controls (HC; n = 73). Results showed that HSV-1, but not cytomegalovirus (CMV) or human herpes virus type 6 (HHV-6) antibody titers were significantly higher in PD compared to HC (p = 0.045). The rs1859788 polymorphism was not differentially distributed between PD and HC, but the minor allele A was more frequently carried by PD (68%) compared to HC (50%) (p = 0.06). Notably, the rs1859788 minor allele A was statically more frequent in male PD (65%) compared to male HC (37%) (p = 0.036). Finally, no relation was found between HSV-1 antibody titers and PILRA genotype. Results herein suggest an involvement of HSV-1 in PD and indicate a possible interaction between PILRA gene polymorphisms and this neuropathology.

Entities:  

Keywords:  HSV-1; Parkinson’s disease; antibody titers; paired immunoglobulin-like type 2 receptor alpha; rehabilitation

Year:  2021        PMID: 34206597     DOI: 10.3390/vaccines9070686

Source DB:  PubMed          Journal:  Vaccines (Basel)        ISSN: 2076-393X


  46 in total

Review 1.  Herpes simplex virus type 1 persists in the aged brain through hypothetical expression of accessory genes.

Authors:  Isamu Mori
Journal:  J Neurovirol       Date:  2010-05       Impact factor: 2.643

Review 2.  Non-motor symptoms in Parkinson's disease.

Authors:  Ronald F Pfeiffer
Journal:  Parkinsonism Relat Disord       Date:  2015-09-03       Impact factor: 4.891

3.  Bilateral striatal lesion due to herpesvirus-6 infection.

Authors:  Rubens Gisbert Cury; Willian Omar Contreras Lopez
Journal:  J Neurol Sci       Date:  2015-10-09       Impact factor: 3.181

4.  Highly pathogenic H5N1 influenza virus can enter the central nervous system and induce neuroinflammation and neurodegeneration.

Authors:  Haeman Jang; David Boltz; Katharine Sturm-Ramirez; Kennie R Shepherd; Yun Jiao; Robert Webster; Richard J Smeyne
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-10       Impact factor: 11.205

Review 5.  Parkinson's disease: the dual hit theory revisited.

Authors:  Christopher H Hawkes; Kelly Del Tredici; Heiko Braak
Journal:  Ann N Y Acad Sci       Date:  2009-07       Impact factor: 5.691

Review 6.  Systematic review of levodopa dose equivalency reporting in Parkinson's disease.

Authors:  Claire L Tomlinson; Rebecca Stowe; Smitaa Patel; Caroline Rick; Richard Gray; Carl E Clarke
Journal:  Mov Disord       Date:  2010-11-15       Impact factor: 10.338

7.  Herpes simplex virus infection causes cellular beta-amyloid accumulation and secretase upregulation.

Authors:  Matthew A Wozniak; Ruth F Itzhaki; Suzanne J Shipley; Curtis B Dobson
Journal:  Neurosci Lett       Date:  2007-10-13       Impact factor: 3.046

8.  Herpes simplex virus antibodies in patients with Parkinson's disease.

Authors:  R J Marttila; U K Rinne
Journal:  J Neurol Sci       Date:  1978-02       Impact factor: 3.181

Review 9.  The molecular basis of herpes simplex virus latency.

Authors:  Michael P Nicoll; João T Proença; Stacey Efstathiou
Journal:  FEMS Microbiol Rev       Date:  2012-01-10       Impact factor: 16.408

10.  Plasma and Serum Alpha-Synuclein as a Biomarker of Diagnosis in Patients With Parkinson's Disease.

Authors:  Chun-Wei Chang; Shieh-Yueh Yang; Che-Chuan Yang; Chia-Wen Chang; Yih-Ru Wu
Journal:  Front Neurol       Date:  2020-01-21       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.